Inappropriate gonadotropin secretion in polycystic ovary syndrome

Fertility and Sterility

Volumn 91, Issue 4, 2009, Pages 1168-1174

  Hsu, Ming I ^a   Liou, Tsan Hon ^a   Liang, So Jung ^a   Su, Hung Wen ^a   Wu, Chien Hua ^a,b   Hsu, Chun Sen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

diagnosis; gonadotropin; LH; LH to FSH ratio; obesity; oligomenorrhea; PCOS

Indexed keywords

FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE;

ADOLESCENT; ADULT; ANOVULATION; ARTICLE; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMANS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OBESITY; POLYCYSTIC OVARY SYNDROME; PROLACTIN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 62949131714     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.01.036     Document Type: Article

References (30)

1. Carmina E., and Lobo R.A. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84 (1999) 1897-1899
2. Abbott D.H., Barnett D.K., Bruns C.M., and Dumesic D.A. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?. Hum Reprod Update 11 (2005) 357-374
3. Zawadski J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A., Givens J.R., and Haseltine F. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Boston, MA 377-384
4. The Rotterdam ESHRE/ASRM-sponsored PCOS workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
5. Hsu M.I., Liou T.H., Chou S.Y., Chang C.Y., and Hsu C.S. Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril 88 (2007) 727-729
6. Bloom M.S., Schisterman E.F., and Hediger M.L. Selecting controls is not selecting "normals": design and analysis issues for studying the etiology of polycystic ovary syndrome. Fertil Steril 86 (2006) 1-12
7. Taylor A.E. Gonadotropin dysfunction in women with polycystic ovary syndrome. Fertil Steril 86 Suppl 1 (2006) S12
8. Taylor A.E., McCourt B., Martin K.A., Anderson E.J., Adams J.M., Schoenfeld D., et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82 (1997) 2248-2256
9. Turhan N.O., Toppare M.F., Seckin N.C., and Dilmen G. The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea. Gynecol Obstet Invest 48 (1999) 183-186
10. Cho L.W., Jayagopal V., Kilpatrick E.S., Holding S., and Atkin S.L. The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome. Ann Clin Biochem 43 (2006) 217-219
11. Robinson S., Rodin D.A., Deacon A., Wheeler M.J., and Clayton R.N. Which hormone tests for the diagnosis of polycystic ovary syndrome?. Br J Obstet Gynaecol 99 (1992) 232-238
12. Waldstreicher J., Santoro N.F., Hall J.E., Filicori M., and Crowley W.F. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 66 (1988) 165-172
13. Burger C.W., Korsen T., van Kessel H., van Dop P.A., Caron F.J., and Schoemaker J. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea. J Clin Endocrinol Metab 61 (1985) 1126-1132
14. Liao C.C., Lin S.Y., Lin H.W., Chen K.H., Chang L.H., Chen S.T., et al. Menstrual abnormalities in a woman with ACTH-dependent pituitary macroadenoma mimicking polycystic ovary syndrome. Taiwan J Obstet Gynecol 45 (2006) 176-179
15. Hatch R., Rosenfield R.L., Kim M.H., and Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140 (1981) 815-830
16. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83 (1988) 3078-3082
17. Must A., Dallal G.E., and Dietz W.H. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr 53 (1991) 839-846
18. Jonard S., Robert Y., and Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod 20 (2005) 2893-2898
19. Nardo L.G., Buckett W.M., and Khullar V. Determination of the best-fitting ultrasound formulaic method for ovarian volume measurement in women with polycystic ovary syndrome. Fertil Steril 79 (2003) 632-633
20. Balen A.H., Laven J.S., Tan S.L., and Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9 (2003) 505-514
21. Zweig M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39 (1993) 561-577
22. Escobar-Morreale H.F., Asunción M., Calvo R.M., Sancho J., and San Millán J.L. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 145 (2001) 619-624
23. Balen A., and Michelmore K. What is polycystic ovary syndrome? Are national views important?. Hum Reprod 17 (2002) 2219-2227
24. Minakami H., Abe N., Oka N., Kimura K., Tamura T., and Tamada T. Prolactin release in polycystic ovarian syndrome. Endocrinol Jpn 35 (1988) 303-310
25. Papaleo E., Doldi N., De Santis L., Marelli G., Marsiglio E., Rofena S., and Ferrari A. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum Reprod 16 (2001) 2263-2266
26. Iwasa T., Matsuzaki T., Tanaka N., Minakuchi M., Shimizu F., Ogata R., et al. Comparison and problems of measured values of LH, FSH, and PRL among measurement systems. Endocr J 53 (2006) 101-109
27. Taponen S., Martikainen H., Järvelin M.R., Sovio U., Laitinen J., Pouta A., et al. Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab 89 (2004) 2114-2118
28. Quinkler M., Sinha B., Tomlinson J.W., Bujalska I.J., Stewart P.M., and Arlt W. Androgen generation in adipose tissue in women with simple obesity-a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. J Endocrinol 183 (2004) 331-342
29. Arroyo A., Laughlin G.A., Morales A.J., and Yen S.S. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 82 (1997) 3728-3733
30. Pagan Y.L., Srouji S.S., Jimenez Y., Emerson A., Gill S., and Hall J.E. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab 91 (2006) 1309-1316